Skip to main content

Table 2 Basic clinical data of survival and death patients with ACLF

From: The high level of IL-1β in the serum of ACLF patients induces increased IL-8 expression in hUC-MSCs and reduces the efficacy of hUC-MSCs in liver failure

Groups

Survival (n = 89)

Death (n = 56)

P value

Age (years)

47 ± 11

53 ± 13

0.232

Sex, male /female

72/17

47/9

0.112

INR

2.17 ± 0.8

2.67 ± 0.92

 < 0.001

TBiL (μmol/L)

411 (304.8–505.1)

477.31 (371.4–562.5)

 < 0.001

ALT (IU/L)

92(57–231)

113(63–284)

0.176

ALB(g/L)

31.69 ± 4.03

32.47 ± 3.06

0.342

Cr (μmol/L)

86.53 ± 22.68

97.2 ± 24.4

0.157

WBC(× 109/L)

7.05 ± 2.7

7.68 ± 2.12

0.253

PLT(× 109/L)

95 (60–133.5)

85.7 (43.5–116.5)

0.084

AFP(ng/ml)

130.78 (7.6–140.5)

105.71 (6.8–128.1)

0.023